Max Robotics — Global Service Robot Directory + US Certification

About

Mario Gasparri is a leading researcher in the field of cardiac electrophysiology, with a specific focus on advancing the treatment of persistent and long-standing atrial fibrillation (AF). His work centers on the development and refinement of robotic-enhanced hybrid ablation (RE-HA), a minimally invasive technique that combines epicardial and endocardial approaches to improve outcomes for patients with complex arrhythmias. Gasparri’s major contributions include demonstrating the feasibility, safety, and early efficacy of robotic-enhanced epicardial ablation as a first-stage hybrid procedure, as detailed in his 2024 study (11 citations). He has also identified critical biophysical predictors of effective ablation, such as local epicardial radiofrequency lesion characteristics, and explored the role of functional gaps and atrial fibrosis in early arrhythmia recurrence (2025, 1 citation). With a growing citation impact, Gasparri’s work is shaping the next generation of AF management, offering new insights into patient selection and procedural optimization. His research is particularly notable for its translational value, bridging advanced robotic technology with clinical outcomes to reduce AF recurrence and improve quality of life.